Iranian Journal of Medical Sciences

Bioinformatics Prediction and Experimental Confirmation of a Novel miRNA in the Fibroblast Growth Factor Receptor 1 (FGFR1) Gene

Document Type : Original Article(s)

Authors

1 Division of Genetics, Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran

2 Biomedical Research Building, Department of Human Genetics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, 33136, USA

10.30476/ijms.2026.109524.4486
Abstract
Background: MicroRNAs (miRNAs) are small non-coding RNAs that regulate multiple key cellular processes, including proliferation and differentiation. Since many miRNAs arise from cancer-related genomic regions, we examined the fibroblast growth factor receptor 1 (FGFR1) genomic region, a locus frequently altered in several cancers, to identify potential novel miRNAs.
Methods: This study was conducted at the University of Isfahan, Iran, between 2019 and 2022. The FGFR1 region was analyzed using sequence-based miRNA prediction tools, sequence read archive (SRA) expression screening, and target-gene prediction algorithms. Among predicted precursors, one high-confidence candidate (FGFR1-premir1) was selected for experimental validation. FGFR1-premir1 was transfected into HEK293T cells to assess its mature form (FGFR1-miR1) processing and impact on predicted target genes using real-time quantitative PCR (qPCR). Statistical analyses were conducted using GraphPad Prism (version 8.0.2), employing one-way analysis of variance (ANOVA) with Tukey’s post hoc test and Pearson’s correlation coefficient test. A P<0.05 was considered statistically significant.
Results: Bioinformatics screening identified 21 putative pre-miRNAs, with 11 prioritized for further analysis. Approximately 43% of predicted target genes involved cancer-associated pathways. Several precursors (including put-premir 11, 12, 16, 17, and 20) emerged as promising candidates. Experimental assays confirmed FGFR1-premir1 produced mature FGFR1-miR1, and its overexpression significantly reduced breast cancer 1 (BRCA1) mRNA levels. Functional analysis using the Database for Annotation, Visualization and Integrated Discovery (DAVID) indicated enrichment in invasion and metastasis pathways.
Conclusion: FGFR1-miR1 was identified as a novel miRNA derived from the FGFR1 genomic region. Its BRCA1 modulation suggests possible functional relevance, although further studies are necessary to validate its role and to characterize additional predicted miRNAs.

Highlights

Maryam Parvaresh (Google Scholar)
Majid Motovali-Bashi (Google Scholar)

Keywords


1.     Bagban M, Sharma K, Saifi S, Ilangovan I, Sultana S, Numanoğlu EN, et al. miR-96 and its versatile role in cancer. Advances in Cancer Biology - Metastasis. 2023;7:100082. doi: https://doi.org/10.1016/j.adcanc.2022.100082.
2.     Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20:5-20. doi: 10.1038/s41580-018-0059-1. PubMed PMID: 30228348.
3.     Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G. Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2019;20:1836-52. doi: 10.1093/bib/bby054. PubMed PMID: 29982332; PubMed Central PMCID: PMC7414524.
4.     Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed Pharmacother. 2021;138:111528. doi: 10.1016/j.biopha.2021.111528. PubMed PMID: 33770669.
5.     Soh J, Cho H, Choi CH, Lee H. Identification and Characterization of MicroRNAs Associated with Somatic Copy Number Alterations in Cancer. Cancers (Basel). 2018;10. doi: 10.3390/cancers10120475. PubMed PMID: 30501131; PubMed Central PMCID: PMC6315597.
6.     Fan S, Chen Y, Wang W, Xu W, Tian M, Liu Y, et al. Pharmacological and Biological Targeting of FGFR1 in Cancer. Curr Issues Mol Biol. 2024;46:13131-50. doi: 10.3390/cimb46110783. PubMed PMID: 39590377; PubMed Central PMCID: PMC11593329.
7.     Erber R, Rubner M, Davenport S, Hauke S, Beckmann MW, Hartmann A, et al. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients. Breast Cancer Res Treat. 2020;184:311-24. doi: 10.1007/s10549-020-05865-2. PubMed PMID: 32852708; PubMed Central PMCID: PMC7599145.
8.     Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:D155-D62. doi: 10.1093/nar/gky1141. PubMed PMID: 30423142; PubMed Central PMCID: PMC6323917.
9.     Alles J, Fehlmann T, Fischer U, Backes C, Galata V, Minet M, et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res. 2019;47:3353-64. doi: 10.1093/nar/gkz097. Pub
10.  Çakmak E. Computational and experimental tools of miRNAs in cancer. Middle East J Cancer. 2020;11:381-9.
11.  Zhou L, Yang J, Ma S, Gao H. Effect of miRNA-136-targeted regulation of FGFR1 on proliferation and apoptosis of triple-negative breast cancer cells. Am J Transl Res. 2021;13:7723-9. PubMed PMID: 34377249; PubMed Central PMCID: PMC8340197.
12.  Yang Y, Li Z, Yuan H, Ji W, Wang K, Lu T, et al. Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer. Oncogenesis. 2019;8:50. doi: 10.1038/s41389-019-0151-1. PubMed PMID: 31492847; PubMed Central PMCID: PMC6731303.
13.  Oulas A, Boutla A, Gkirtzou K, Reczko M, Kalantidis K, Poirazi P. Prediction of novel microRNA genes in cancer-associated genomic regions--a combined computational and experimental approach. Nucleic Acids Res. 2009;37:3276-87. doi: 10.1093/nar/gkp120. PubMed PMID: 19324892; PubMed Central PMCID: PMC2691815.
14.  Gao D, Middleton R, Rasko JE, Ritchie W. miREval 2.0: a web tool for simple microRNA prediction in genome sequences. Bioinformatics. 2013;29:3225-6. doi: 10.1093/bioinformatics/btt545. PubMed PMID: 24048357; PubMed Central PMCID: PMC5994938.
15.  Ahmed F, Kaundal R, Raghava GP. PHDcleav: a SVM based method for predicting human Dicer cleavage sites using sequence and secondary structure of miRNA precursors. BMC Bioinformatics. 2013;14:S9. doi: 10.1186/1471-2105-14-S14-S9. PubMed PMID: 24267009; PubMed Central PMCID: PMC3851333.
16.  Jiang P, Wu H, Wang W, Ma W, Sun X, Lu Z. MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features. Nucleic Acids Res. 2007;35:W339-44. doi: 10.1093/nar/gkm368. PubMed PMID: 17553836; PubMed Central PMCID: PMC1933124.
17.  Liu B, Fang L, Liu F, Wang X, Chen J, Chou KC. Identification of real microRNA precursors with a pseudo structure status composition approach. PLoS One. 2015;10:e0121501. doi: 10.1371/journal.pone.0121501. PubMed PMID: 25821974; PubMed Central PMCID: PMC4378912
18.  Liu B, Fang L, Liu F, Wang X, Chou KC. iMiRNA-PseDPC: microRNA precursor identification with a pseudo distance-pair composition approach. J Biomol Struct Dyn. 2016;34:223-35. doi: 10.1080/07391102.2015.1014422. PubMed PMID: 25645238.
19.  Liu B, Fang L, Chen J, Liu F, Wang X. miRNA-dis: microRNA precursor identification based on distance structure status pairs. Mol Biosyst. 2015;11:1194-204. doi: 10.1039/c5mb00050e. PubMed PMID: 25715848.
20.  Chen J, Wang X, Liu B. iMiRNA-SSF: Improving the Identification of MicroRNA Precursors by Combining Negative Sets with Different Distributions. Sci Rep. 2016;6:19062. doi: 10.1038/srep19062. PubMed PMID: 26753561; PubMed Central PMCID: PMC4709562.
21.  Liu B, Fang L, Wang S, Wang X, Li H, Chou KC. Identification of microRNA precursor with the degenerate K-tuple or Kmer strategy. J Theor Biol. 2015;385:153-9. doi: 10.1016/j.jtbi.2015.08.025. PubMed PMID: 26362104.
22.  Gkirtzou K, Tsamardinos I, Tsakalides P, Poirazi P. MatureBayes: a probabilistic algorithm for identifying the mature miRNA within novel precursors. PLoS One. 2010;5:e11843. doi: 10.1371/journal.pone.0011843. PubMed PMID: 20700506; PubMed Central PMCID: PMC2917354.
23.  Shen W, Chen M, Wei G, Li Y. MicroRNA prediction using a fixed-order Markov model based on the secondary structure pattern. PLoS One. 2012;7:e48236. doi: 10.1371/journal.pone.0048236. PubMed PMID: 23118959; PubMed Central PMCID: PMC3484136.
24.  Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48:D127-D31. doi: 10.1093/nar/gkz757. PubMed PMID: 31504780; PubMed Central PMCID: PMC6943051.
25.  Reczko M, Maragkakis M, Alexiou P, Grosse I, Hatzigeorgiou AG. Functional microRNA targets in protein coding sequences. Bioinformatics. 2012;28:771-6. doi: 10.1093/bioinformatics/bts043. PubMed PMID: 22285563.
26.  Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216-W21. doi: 10.1093/nar/gkac194. PubMed PMID: 35325185; PubMed Central PMCID: PMC9252805.
27.  Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215. doi: 10.1093/nar/16.3.1215. PubMed PMID: 3344216; PubMed Central PMCID: PMC334765.
28.  Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell. 2009;137:647-58. doi: 10.1016/j.cell.2009.02.038. PubMed PMID: 19409607.
29.  da Conceicao Braga L, Goncalves BOP, Coelho PL, da Silva Filho AL, Silva LM. Identification of best housekeeping genes for the normalization of RT-qPCR in human cell lines. Acta Histochem. 2022;124:151821. doi: 10.1016/j.acthis.2021.151821. PubMed PMID: 34861601.
30.  Bignotti E, Calza S, Tassi RA, Zanotti L, Bandiera E, Sartori E, et al. Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues. J Cell Mol Med. 2016;20:2341-8. doi: 10.1111/jcmm.12927. PubMed PMID: 27419385; PubMed Central PMCID: PMC5134371.
31.  Shabaninejad Z, Mowla SJ, Yousefi F, Soltani BM. A Novel miRNA Located in the HER2 Gene Shows an Inhibitory Effect on Wnt Signaling and Cell Cycle Progression. Biomed Res Int. 2022;2022:7216758. doi: 10.1155/2022/7216758. PubMed PMID: 35747498; PubMed Central PMCID: PMC9213177.
32.  Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101-8. doi: 10.1038/nprot.2008.73. PubMed PMID: 18546601.
33.  Steiman-Shimony A, Shtrikman O, Margalit H. Assessing the functional association of intronic miRNAs with their host genes. RNA. 2018;24:991-1004. doi: 10.1261/rna.064386.117. PubMed PMID: 29752351; PubMed Central PMCID: PMC6049507.
34.  Riolo G, Cantara S, Marzocchi C, Ricci C. miRNA Targets: From Prediction Tools to Experimental Validation. Methods Protoc. 2020;4. doi: 10.3390/mps4010001. PubMed PMID: 33374478; PubMed Central PMCID: PMC7839038.
35.  Calin GA. Being Small and Intronic: miRNAs That Count! Cancer Res. 2021;81:1212-3. doi: 10.1158/0008-5472.CAN-20-4172. PubMed PMID: 33822742.
36.  Zhou Y, Yuan Y, Li L, Wang X, Quan Y, Liu C, et al. HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer. PLoS One. 2021;16:e0245832. doi: 10.1371/journal.pone.0245832. PubMed PMID: 33529238; PubMed Central PMCID: PMC7853520.
37.  Tomasello L, Distefano R, Nigita G, Croce CM. The MicroRNA Family Gets Wider: The IsomiRs Classification and Role. Front Cell Dev Biol. 2021;9:668648. doi: 10.3389/fcell.2021.668648. PubMed PMID: 34178993; PubMed Central PMCID: PMC8220208.
38.  Rahimi A, Sedighi R, Emadi-Baygi M, Honardoost MA, Mowla SJ, Khanahmad H, et al. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer. J Cell Biochem. 2020;121:1307-16. doi: 10.1002/jcb.29367. PubMed PMID: 31489987.
39.  Oh M, Rhee S, Moon JH, Chae H, Lee S, Kang J, et al. Literature-based condition-specific miRNA-mRNA target prediction. PLoS One. 2017;12:e0174999. doi: 10.1371/journal.pone.0174999. PubMed PMID: 28362846; PubMed Central PMCID: PMC5376335.
40.   Fu X, Tan W, Song Q, Pei H, Li J. BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies. Front Cell Dev Biol. 2022;10:813457. doi: 10.3389/fcell.2022.813457. PubMed PMID: 35300412; PubMed Central PMCID: PMC8921524.

Articles InPress, Corrected Proof
Available Online from 22 November 2026


  • Received 08 November 2025
  • Revised 30 May 2026
  • Accepted 23 June 2026